Background It is unclear whether adjuvant or early salvage radiotherapy following radical
prostatectomy is more appropriate for men who present with localised or locally advanced …

How to manage patients with prostate cancer (PCa) with biochemical recurrence (BCR)
following primary curative treatment is a controversial issue. Importantly, this prostate …

Purpose We aimed to update a previously published, multi-institutional nomogram of
outcomes for salvage radiotherapy (SRT) following radical prostatectomy (RP) for prostate …

Purpose The optimal timing of postoperative radiotherapy (RT) after radical prostatectomy
(RP) is unclear. We hypothesized that a genomic classifier (GC) would provide prognostic …

Purpose Despite documented oncologic benefit, use of postoperative adjuvant radiotherapy
(aRT) in patients with prostate cancer is still limited in the United States. We aimed to …

Purpose: Early salvage radiotherapy following radical prostatectomy for prostate cancer is
commonly advocated in place of adjuvant radiotherapy. We aimed to determine the optimal …

An increased molecular understanding of localized prostate cancer and the improved ability
for molecular testing of pathologic tissue has led to the development of multiple clinical …

Importance Prostate cancer with adverse pathological features (ie, pT3 and/or positive
margins) after prostatectomy may be managed with adjuvant radiotherapy (ART) or …

Objective The ARO 96-02 trial primarily compared wait-and-see (WS, arm A) with adjuvant
radiation therapy (ART, arm B) in prostate cancer patients who achieved an undetectable …

Background Despite salvage radiation therapy (SRT) for recurrent prostate cancer (PCa)
after radical prostatectomy (RP), some patients still progress to metastases. Identifying these …